The sodium-glutamate antagonist riluzole improves outcome after acute spinal cord injury: results from the RISCIS randomised controlled trial analysed using a global statistical analytic technique

Update your browser to view ScienceDirect correctly.

Your technical details and browser version:

Request ID: 96a7828a1890ebe9-LAX IP: 47.97.18.252 UTC time: 2025-08-05T16:00:52+00:00 Browser: Mozilla/5.0 (X11; U; Linux x86_64; en-US; rv:1.9.1.4) Gecko/20091030 Gentoo Firefox/3.5.4